We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
PTGS2
SECTIONS
  • TISSUE
  • BRAIN
  • SINGLE CELL TYPE
  • TISSUE CELL TYPE
  • PATHOLOGY
  • DISEASE
  • IMMUNE CELL
  • BLOOD PROTEIN
  • SUBCELLULAR
  • CELL LINE
  • STRUCTURE
  • METABOLIC
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
  • SARS-COV-2
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Patient ID
Tissue
Category
Cluster
Reliability
Brain region
Category
Brain region
Category
Brain region
Category
Reliability
Cell type
Category
Cluster
Tissue
Cell type
Enrichment
Cancer
Prognosis
Cancer
Category
Cell type
Category
Cell lineage
Category
Cluster
Annotation
Disease
Location
Searches
Location
Cell line
Type
Phase
Reliability
Cancer type
Category
Cluster
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Protein structure
In atlas
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • TISSUE CELL

  • PATHOLOGY

  • DISEASE

  • IMMUNE

  • BLOOD

  • SUBCELL

  • CELL LINE

  • STRUCTURE

  • METABOLIC

  • PTGS2
PROTEIN STRUCTURE
ANTIBODIES
AND
VALIDATION
Protein structures
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

PTGS2
Synonyms COX2
Gene descriptioni

Full gene name according to HGNC.

Prostaglandin-endoperoxide synthase 2
Protein classi

Assigned HPA protein class(es) for the encoded protein(s).

Read more
Cancer-related genes
Enzymes
FDA approved drug targets
Human disease related genes
Metabolic proteins
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Read more
Intracellular
Protein evidence Evidence at protein level (all genes)
GENE INFORMATIONi

Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.

Chromosome 1
Cytoband q31.1
Chromosome location (bp) 186671791 - 186680922
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

2
Ensembl ENSG00000073756 (version 103.38)
Entrez gene 5743
HGNC HGNC:9605
UniProt P35354 (UniProt - Evidence at protein level)
neXtProt NX_P35354
Antibodypedia PTGS2 antibodies


PROTEIN STRUCTUREi

The Structure section provides predicted structures from the Alphafold protein structure database and available experimental structures from Protein Data Bank (PDB).

In the Structure drop-down menu all experimental structures from PDB are available for selection and display. The structures are displayed using the NGL Viewer and can be zoomed-in and rotated either manually or by checking the Autorotate box. The Color scheme can be selected to show the residue index, chain name or confidence score (as B-factors and pLDDT score for experimental and predicted structures, respectively). The positions for available antigen sequences in the structure are shown if Antigens is turned to ON, and the Variants slider can be used to show the positions of clinical and population variants.https://github.com/nglviewer/ngl

Read more

Predicted


Description: Structure prediction from Alphafold project. Structure version 2

# Chains: 1      # Clinical variants: 0      # Population variants: 248

Experimental

Description: The Structure of Meclofenamic Acid Bound to Human Cyclooxygenase-2 (X-ray)

# Chains: 1      # Clinical variants: 0      # Population variants: 0

Antigens:

Off
On

Variants:

Off
Clinical
Population

Color scheme:

Confidence
Residue index
Chain name

Autorotate:

Off
On



PROTEIN BROWSERi

The protein browser displays the antigen location on the target protein(s) and the features of the target protein. The tabs at the top of the protein view section can be used to switch between the different splice variants to which an antigen has been mapped.

At the top of the view, the position of the antigen (identified by the corresponding HPA identifier) is shown as a green bar. A yellow triangle on the bar indicates a <100% sequence identity to the protein target.

Below the antigens, the maximum percent sequence identity of the protein to all other proteins from other human genes is displayed, using a sliding window of 10 aa residues (HsID 10) or 50 aa residues (HsID 50). The region with the lowest possible identity is always selected for antigen design, with a maximum identity of 60% allowed for designing a single-target antigen (read more).

The curve in blue displays the predicted antigenicity i.e. the tendency for different regions of the protein to generate an immune response, with peak regions being predicted to be more antigenic.The curve shows average values based on a sliding window approach using an in-house propensity scale. (read more).

If a signal peptide is predicted by a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius (turquoise) and/or transmembrane regions (orange) are predicted by MDM, these are displayed.

Low complexity regions are shown in yellow and InterPro regions in green. Common (purple) and unique (grey) regions between different splice variants of the gene are also displayed (read more), and at the bottom of the protein view is the protein scale.
PTGS2-201
PTGS2-205


PROTEIN INFORMATIONi

The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.

The ENSP identifier links to the Ensembl website protein summary, while the ENST identifier links to the Ensembl website transcript summary for the selected splice variant. The data in the UniProt column can be expanded to show links to all matching UniProt identifiers for this protein.

The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.

The Gene Ontology terms assigned to this protein are listed if expanding the Gene ontology column. The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide (according to a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius) and the number of predicted transmembrane region(s) (according to MDM) are also reported.
Splice variant UniProt Protein class Gene ontology Length & mass Signal peptide
(predicted)
Transmembrane regions
(predicted)
PTGS2-201
ENSP00000356438
ENST00000367468
P35354 [Direct mapping]
Prostaglandin G/H synthase 2
Show all
Enzymes
   ENZYME proteins
   Oxidoreductases
Metabolic proteins
   THUMBUP predicted membrane proteins
   Secreted proteins predicted by MDSEC
   SignalP predicted secreted proteins
   Phobius predicted secreted proteins
   SPOCTOPUS predicted secreted proteins
Predicted intracellular proteins
Cancer-related genes
   Candidate cancer biomarkers
FDA approved drug targets
   Biotech drugs
   Small molecule drugs
Human disease related genes
   Cancers
   Cancers of the digestive system
   Cancers of male genital organs
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0001516 [prostaglandin biosynthetic process]
GO:0004601 [peroxidase activity]
GO:0004666 [prostaglandin-endoperoxide synthase activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005637 [nuclear inner membrane]
GO:0005640 [nuclear outer membrane]
GO:0005737 [cytoplasm]
GO:0005783 [endoplasmic reticulum]
GO:0005788 [endoplasmic reticulum lumen]
GO:0005789 [endoplasmic reticulum membrane]
GO:0006629 [lipid metabolic process]
GO:0006631 [fatty acid metabolic process]
GO:0006633 [fatty acid biosynthetic process]
GO:0006693 [prostaglandin metabolic process]
GO:0006954 [inflammatory response]
GO:0006979 [response to oxidative stress]
GO:0008217 [regulation of blood pressure]
GO:0010575 [positive regulation of vascular endothelial growth factor production]
GO:0016020 [membrane]
GO:0016491 [oxidoreductase activity]
GO:0019221 [cytokine-mediated signaling pathway]
GO:0019371 [cyclooxygenase pathway]
GO:0019372 [lipoxygenase pathway]
GO:0019899 [enzyme binding]
GO:0020037 [heme binding]
GO:0031090 [organelle membrane]
GO:0031394 [positive regulation of prostaglandin biosynthetic process]
GO:0031622 [positive regulation of fever generation]
GO:0034356 [NAD biosynthesis via nicotinamide riboside salvage pathway]
GO:0042759 [long-chain fatty acid biosynthetic process]
GO:0043005 [neuron projection]
GO:0043231 [intracellular membrane-bounded organelle]
GO:0045429 [positive regulation of nitric oxide biosynthetic process]
GO:0046872 [metal ion binding]
GO:0050727 [regulation of inflammatory response]
GO:0051213 [dioxygenase activity]
GO:0055114 [oxidation-reduction process]
GO:0071456 [cellular response to hypoxia]
GO:0071636 [positive regulation of transforming growth factor beta production]
GO:0090050 [positive regulation of cell migration involved in sprouting angiogenesis]
GO:0090271 [positive regulation of fibroblast growth factor production]
GO:0090336 [positive regulation of brown fat cell differentiation]
GO:0090362 [positive regulation of platelet-derived growth factor production]
GO:0098869 [cellular oxidant detoxification]
GO:0150077 [regulation of neuroinflammatory response]
Show all
604 aa
69 kDa
Yes 0
PTGS2-205
ENSP00000506242
ENST00000680451
Metabolic proteins
   MEMSAT3 predicted membrane proteins
   THUMBUP predicted membrane proteins
   Secreted proteins predicted by MDSEC
   SignalP predicted secreted proteins
   Phobius predicted secreted proteins
   SPOCTOPUS predicted secreted proteins
Predicted intracellular proteins
Human disease related genes
   Cancers
   Cancers of the digestive system
   Cancers of male genital organs
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0001516 [prostaglandin biosynthetic process]
GO:0001525 [angiogenesis]
GO:0004601 [peroxidase activity]
GO:0004666 [prostaglandin-endoperoxide synthase activity]
GO:0005637 [nuclear inner membrane]
GO:0005640 [nuclear outer membrane]
GO:0005737 [cytoplasm]
GO:0005901 [caveola]
GO:0006954 [inflammatory response]
GO:0006979 [response to oxidative stress]
GO:0007566 [embryo implantation]
GO:0007568 [aging]
GO:0007612 [learning]
GO:0007613 [memory]
GO:0008217 [regulation of blood pressure]
GO:0008284 [positive regulation of cell population proliferation]
GO:0008285 [negative regulation of cell population proliferation]
GO:0009314 [response to radiation]
GO:0009750 [response to fructose]
GO:0010033 [response to organic substance]
GO:0010042 [response to manganese ion]
GO:0010226 [response to lithium ion]
GO:0010243 [response to organonitrogen compound]
GO:0010575 [positive regulation of vascular endothelial growth factor production]
GO:0010942 [positive regulation of cell death]
GO:0014070 [response to organic cyclic compound]
GO:0016702 [oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen]
GO:0019233 [sensory perception of pain]
GO:0019371 [cyclooxygenase pathway]
GO:0020037 [heme binding]
GO:0030282 [bone mineralization]
GO:0030728 [ovulation]
GO:0031394 [positive regulation of prostaglandin biosynthetic process]
GO:0031622 [positive regulation of fever generation]
GO:0031915 [positive regulation of synaptic plasticity]
GO:0032227 [negative regulation of synaptic transmission, dopaminergic]
GO:0032355 [response to estradiol]
GO:0032496 [response to lipopolysaccharide]
GO:0032991 [protein-containing complex]
GO:0033138 [positive regulation of peptidyl-serine phosphorylation]
GO:0033280 [response to vitamin D]
GO:0034097 [response to cytokine]
GO:0034605 [cellular response to heat]
GO:0034612 [response to tumor necrosis factor]
GO:0034644 [cellular response to UV]
GO:0035633 [maintenance of blood-brain barrier]
GO:0042127 [regulation of cell population proliferation]
GO:0042307 [positive regulation of protein import into nucleus]
GO:0042493 [response to drug]
GO:0042633 [hair cycle]
GO:0042803 [protein homodimerization activity]
GO:0043005 [neuron projection]
GO:0043065 [positive regulation of apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043154 [negative regulation of cysteine-type endopeptidase activity involved in apoptotic process]
GO:0045429 [positive regulation of nitric oxide biosynthetic process]
GO:0045786 [negative regulation of cell cycle]
GO:0045907 [positive regulation of vasoconstriction]
GO:0045986 [negative regulation of smooth muscle contraction]
GO:0045987 [positive regulation of smooth muscle contraction]
GO:0046697 [decidualization]
GO:0048661 [positive regulation of smooth muscle cell proliferation]
GO:0050873 [brown fat cell differentiation]
GO:0051384 [response to glucocorticoid]
GO:0051926 [negative regulation of calcium ion transport]
GO:0051968 [positive regulation of synaptic transmission, glutamatergic]
GO:0055114 [oxidation-reduction process]
GO:0070542 [response to fatty acid]
GO:0071260 [cellular response to mechanical stimulus]
GO:0071284 [cellular response to lead ion]
GO:0071318 [cellular response to ATP]
GO:0071471 [cellular response to non-ionic osmotic stress]
GO:0071498 [cellular response to fluid shear stress]
GO:0071636 [positive regulation of transforming growth factor beta production]
GO:0090050 [positive regulation of cell migration involved in sprouting angiogenesis]
GO:0090271 [positive regulation of fibroblast growth factor production]
GO:0090336 [positive regulation of brown fat cell differentiation]
GO:0090362 [positive regulation of platelet-derived growth factor production]
GO:0097756 [negative regulation of blood vessel diameter]
GO:0150077 [regulation of neuroinflammatory response]
GO:1902219 [negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress]
GO:1990776 [response to angiotensin]
Show all
604 aa
69 kDa
Yes 0

Contact

  • NEWS ARTICLES
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.